HK1217102A1 - 四環布羅莫結構域抑制劑 - Google Patents
四環布羅莫結構域抑制劑Info
- Publication number
- HK1217102A1 HK1217102A1 HK16105095.5A HK16105095A HK1217102A1 HK 1217102 A1 HK1217102 A1 HK 1217102A1 HK 16105095 A HK16105095 A HK 16105095A HK 1217102 A1 HK1217102 A1 HK 1217102A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- bromodomain inhibitors
- tetracyclic
- tetracyclic bromodomain
- inhibitors
- bromodomain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361777797P | 2013-03-12 | 2013-03-12 | |
US201461928779P | 2014-01-17 | 2014-01-17 | |
PCT/CN2014/000258 WO2014139324A1 (en) | 2013-03-12 | 2014-03-12 | Tetracyclic bromodomain inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1217102A1 true HK1217102A1 (zh) | 2016-12-23 |
Family
ID=51535867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16105095.5A HK1217102A1 (zh) | 2013-03-12 | 2016-05-04 | 四環布羅莫結構域抑制劑 |
Country Status (22)
Country | Link |
---|---|
US (5) | US10035800B2 (zh) |
EP (2) | EP3539962A1 (zh) |
JP (2) | JP6419735B2 (zh) |
KR (1) | KR102224992B1 (zh) |
CN (2) | CN108440528A (zh) |
AR (1) | AR095266A1 (zh) |
AU (2) | AU2014231563A1 (zh) |
BR (1) | BR112015022391B1 (zh) |
CA (1) | CA2903910C (zh) |
CR (1) | CR20150474A (zh) |
DO (1) | DOP2015000216A (zh) |
HK (1) | HK1217102A1 (zh) |
IL (1) | IL241010B (zh) |
MX (1) | MX363913B (zh) |
PE (1) | PE20151788A1 (zh) |
PH (1) | PH12015502004A1 (zh) |
RU (1) | RU2015143192A (zh) |
SG (1) | SG11201507402WA (zh) |
TW (1) | TWI635087B (zh) |
UY (1) | UY35395A (zh) |
WO (1) | WO2014139324A1 (zh) |
ZA (1) | ZA201506477B (zh) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104364239B (zh) | 2012-06-13 | 2017-08-25 | 霍夫曼-拉罗奇有限公司 | 二氮杂螺环烷烃和氮杂螺环烷烃 |
MX368615B (es) | 2012-09-25 | 2019-10-09 | Hoffmann La Roche | Derivados bicíclicos como inhibidores de la autotaxina (atx) que son inhibidores de la producción de ácido lisofosfatídico (lpa) y el uso de los mismos. |
CN108440528A (zh) * | 2013-03-12 | 2018-08-24 | 艾伯维公司 | 四环布罗莫结构域抑制剂 |
AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
US9227985B2 (en) | 2013-03-15 | 2016-01-05 | Incyte Corporation | Tricyclic heterocycles as bet protein inhibitors |
US9290514B2 (en) | 2013-07-08 | 2016-03-22 | Incyte Holdings Corporation | Tricyclic heterocycles as BET protein inhibitors |
WO2015013635A2 (en) | 2013-07-25 | 2015-01-29 | Dana-Farber Cancer Institute, Inc. | Inhibitors of transcription factors and uses thereof |
HUE036117T2 (hu) | 2013-11-26 | 2018-06-28 | Hoffmann La Roche | Oktahidro-ciklobuta[1,2-C;3,4-C']dipirrol származékok, mint autotaxin inhibitorok |
US9315501B2 (en) | 2013-11-26 | 2016-04-19 | Incyte Corporation | Bicyclic heterocycles as BET protein inhibitors |
WO2015081203A1 (en) | 2013-11-26 | 2015-06-04 | Incyte Corporation | Bicyclic heterocycles as bet protein inhibitors |
WO2015095492A1 (en) | 2013-12-19 | 2015-06-25 | Incyte Corporation | Tricyclic heterocycles as bet protein inhibitors |
JP2017504651A (ja) | 2014-01-31 | 2017-02-09 | ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド | ジアゼパン誘導体の使用 |
RU2016134947A (ru) | 2014-01-31 | 2018-03-01 | Дана-Фарбер Кансер Институт, Инк. | Производные диаминопиримидин бензолсульфона и их применение |
MA39792B1 (fr) | 2014-03-26 | 2019-12-31 | Hoffmann La Roche | Composés bicycliques en tant qu'inhibiteurs de production d'autotaxine (atx) et d'acide lysophosphatidique (lpa) |
CN106029667B (zh) | 2014-03-26 | 2019-08-23 | 豪夫迈·罗氏有限公司 | 作为自分泌运动因子(atx)和溶血磷脂酸(lpa)生产抑制剂的稠合[1,4]二氮杂*化合物 |
HUE061770T2 (hu) | 2014-04-23 | 2023-08-28 | Incyte Holdings Corp | 1H-pirrolo[2,3-C]piridin-7(6H)-onok és pirazolo[3,4-C]piridin-7(6H)-onok mint BET fehérjék gátlószerei |
RU2017104897A (ru) | 2014-08-08 | 2018-09-10 | Дана-Фарбер Кэнсер Инститьют, Инк. | Производные диазепана и их применения |
JP2017525759A (ja) | 2014-08-08 | 2017-09-07 | ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド | ジヒドロプテリジノン誘導体およびその使用 |
US9527864B2 (en) | 2014-09-15 | 2016-12-27 | Incyte Corporation | Tricyclic heterocycles as BET protein inhibitors |
MA40940A (fr) * | 2014-11-10 | 2017-09-19 | Constellation Pharmaceuticals Inc | Pyrrolopyridines substituées utilisées en tant qu'inhibiteurs de bromodomaines |
WO2016077375A1 (en) | 2014-11-10 | 2016-05-19 | Genentech, Inc. | Bromodomain inhibitors and uses thereof |
MA40943A (fr) * | 2014-11-10 | 2017-09-19 | Constellation Pharmaceuticals Inc | Pyrrolopyridines substituées utilisées en tant qu'inhibiteurs de bromodomaines |
JP6709792B2 (ja) | 2015-01-29 | 2020-06-17 | ジェネンテック, インコーポレイテッド | 治療用化合物およびその使用 |
GB201504694D0 (en) | 2015-03-19 | 2015-05-06 | Glaxosmithkline Ip Dev Ltd | Covalent conjugates |
JP6764877B2 (ja) | 2015-03-30 | 2020-10-07 | ジュビラント バイオシス リミテッドJubilant Biosys Limited | がん治療に有用な1−(シクロ)アルキルピリジン−2−オンの三環式縮合誘導体 |
MA41898A (fr) | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | Dérivés de quinazolinone bicyclique |
AU2016276963C1 (en) | 2015-06-12 | 2021-08-05 | Dana-Farber Cancer Institute, Inc. | Combination therapy of transcription inhibitors and kinase inhibitors |
UA123362C2 (uk) | 2015-09-04 | 2021-03-24 | Ф. Хоффманн-Ля Рош Аг | Феноксиметильні похідні |
WO2017042834A1 (en) * | 2015-09-09 | 2017-03-16 | Jubilant Biosys Limited | Tricyclic fused pyridin-2-one derivatives and their use as brd4 inhibitors |
US11306105B2 (en) | 2015-09-11 | 2022-04-19 | Dana-Farber Cancer Institute, Inc. | Cyano thienotriazolodiazepines and uses thereof |
SG10202007099TA (en) | 2015-09-11 | 2020-08-28 | Dana Farber Cancer Inst Inc | Acetamide thienotriazoldiazepines and uses thereof |
CN107614505B (zh) | 2015-09-24 | 2021-05-07 | 豪夫迈·罗氏有限公司 | 作为双重atx/ca抑制剂的新型二环化合物 |
AU2016328535A1 (en) | 2015-09-24 | 2017-11-09 | F. Hoffmann-La Roche Ag | Bicyclic compounds as ATX inhibitors |
WO2017050791A1 (en) | 2015-09-24 | 2017-03-30 | F. Hoffmann-La Roche Ag | New bicyclic compounds as dual atx/ca inhibitors |
CA2991615A1 (en) | 2015-09-24 | 2017-03-30 | F. Hoffmann-La Roche Ag | Bicyclic compounds as atx inhibitors |
AR106520A1 (es) | 2015-10-29 | 2018-01-24 | Incyte Corp | Forma sólida amorfa de un inhibidor de proteína bet |
CN114957291A (zh) | 2015-11-25 | 2022-08-30 | 达纳-法伯癌症研究所股份有限公司 | 二价溴结构域抑制剂及其用途 |
EP3693369A3 (en) | 2016-04-15 | 2020-09-09 | AbbVie Inc. | Bromodomain inhibitors |
EP3472157B1 (en) | 2016-06-20 | 2023-04-12 | Incyte Corporation | Crystalline solid forms of a bet inhibitor |
JP2019534306A (ja) | 2016-11-10 | 2019-11-28 | 羅欣薬業(上海)有限公司Luoxin Pharmaceutical(Shanghai) Co., Ltd. | 窒素含有大員環系化合物、その製造方法、薬物組成物および使用 |
CN110167939B (zh) * | 2017-01-11 | 2021-12-31 | 江苏豪森药业集团有限公司 | 吡咯并[2,3-c]吡啶类衍生物、其制备方法及其在医药上的应用 |
AU2018233079B9 (en) | 2017-03-16 | 2021-07-22 | F. Hoffmann-La Roche Ag | Heterocyclic compounds useful as dual ATX/CA inhibitors |
WO2018167113A1 (en) | 2017-03-16 | 2018-09-20 | F. Hoffmann-La Roche Ag | New bicyclic compounds as atx inhibitors |
EP3609896A4 (en) * | 2017-04-14 | 2020-11-04 | AbbVie Inc. | BROMODOMAIN INHIBITORS |
WO2019184919A1 (zh) * | 2018-03-27 | 2019-10-03 | 成都海创药业有限公司 | 一种含有金刚烷的化合物及其在治疗癌症中的用途 |
CN110865130B (zh) * | 2018-08-27 | 2023-08-22 | 北京海晶生物医药科技有限公司 | 一种盐酸奥洛他定及其有关物质的检测方法 |
TW202037381A (zh) | 2018-10-24 | 2020-10-16 | 瑞士商赫孚孟拉羅股份公司 | 綴合化學降解誘導劑及使用方法 |
CN113226322A (zh) | 2018-10-30 | 2021-08-06 | 诺维逊生物股份有限公司 | 作为bet抑制剂的杂环化合物 |
CN109394768B (zh) * | 2018-12-10 | 2019-08-23 | 牡丹江医学院 | 一种治疗湿疹的药物及其制备方法 |
CN111377934B (zh) * | 2018-12-29 | 2023-01-24 | 中国科学院上海药物研究所 | 一类杂环化合物,其制备及用途 |
CA3133131A1 (en) * | 2019-03-17 | 2020-09-24 | Shanghai Ringene Biopharma Co., Ltd. | Pyrrole amidopyridone compound, preparation method therefor and use thereof |
CN114286818A (zh) | 2019-07-02 | 2022-04-05 | 诺维逊生物股份有限公司 | 作为bet抑制剂的杂环化合物 |
WO2021121276A1 (zh) * | 2019-12-17 | 2021-06-24 | 江苏恒瑞医药股份有限公司 | 稠合四环类衍生物、其制备方法及其在医药上的应用 |
US11833155B2 (en) | 2020-06-03 | 2023-12-05 | Incyte Corporation | Combination therapy for treatment of myeloproliferative neoplasms |
AR124681A1 (es) | 2021-01-20 | 2023-04-26 | Abbvie Inc | Conjugados anticuerpo-fármaco anti-egfr |
EP4319748A1 (en) * | 2021-04-09 | 2024-02-14 | Tachyon Therapeutics, Inc. | Treatment of cancer with kdm4 inhibitors |
AU2022303310A1 (en) * | 2021-06-29 | 2024-02-08 | Tay Therapeutics Limited | Pyrrolopyridone derivatives useful in the treatment of cancer |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1887008B1 (en) | 2005-05-30 | 2021-04-21 | Mitsubishi Tanabe Pharma Corporation | Thienotriazolodiazepine compound and a medicinal use thereof |
KR20090082453A (ko) * | 2006-11-01 | 2009-07-30 | 버텍스 파마슈티칼스 인코포레이티드 | 야누스 키나제의 억제제로서 유용한 트리사이클릭 헤테로아릴 화합물 |
RS54645B1 (en) * | 2009-11-05 | 2016-08-31 | Glaxosmithkline Llc | BENZODIAZEPINE AS A BROMODOMEN INHIBITOR |
GB0919426D0 (en) * | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
EP2585465B1 (en) * | 2010-06-22 | 2014-11-12 | GlaxoSmithKline LLC | Benzotriazolodiazepine compounds inhibitors of bromodomains |
AR084070A1 (es) * | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
EP2705039B1 (en) * | 2011-05-04 | 2017-07-26 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
CN108440528A (zh) * | 2013-03-12 | 2018-08-24 | 艾伯维公司 | 四环布罗莫结构域抑制剂 |
-
2014
- 2014-03-12 CN CN201810419623.0A patent/CN108440528A/zh active Pending
- 2014-03-12 KR KR1020157028346A patent/KR102224992B1/ko active IP Right Grant
- 2014-03-12 AR ARP140100878 patent/AR095266A1/es unknown
- 2014-03-12 MX MX2015012006A patent/MX363913B/es active IP Right Grant
- 2014-03-12 BR BR112015022391-5A patent/BR112015022391B1/pt active IP Right Grant
- 2014-03-12 UY UY0001035395A patent/UY35395A/es not_active Application Discontinuation
- 2014-03-12 TW TW103108954A patent/TWI635087B/zh active
- 2014-03-12 EP EP19156935.9A patent/EP3539962A1/en not_active Withdrawn
- 2014-03-12 CN CN201480015201.7A patent/CN105026403B/zh active Active
- 2014-03-12 RU RU2015143192A patent/RU2015143192A/ru not_active Application Discontinuation
- 2014-03-12 AU AU2014231563A patent/AU2014231563A1/en not_active Abandoned
- 2014-03-12 CA CA2903910A patent/CA2903910C/en active Active
- 2014-03-12 WO PCT/CN2014/000258 patent/WO2014139324A1/en active Application Filing
- 2014-03-12 PE PE2015001915A patent/PE20151788A1/es not_active Application Discontinuation
- 2014-03-12 US US14/774,866 patent/US10035800B2/en active Active
- 2014-03-12 SG SG11201507402WA patent/SG11201507402WA/en unknown
- 2014-03-12 JP JP2015561913A patent/JP6419735B2/ja active Active
- 2014-03-12 EP EP14762617.0A patent/EP2970330B1/en active Active
-
2015
- 2015-09-01 IL IL241010A patent/IL241010B/en active IP Right Grant
- 2015-09-03 ZA ZA2015/06477A patent/ZA201506477B/en unknown
- 2015-09-04 DO DO2015000216A patent/DOP2015000216A/es unknown
- 2015-09-08 PH PH12015502004A patent/PH12015502004A1/en unknown
- 2015-09-11 CR CR20150474A patent/CR20150474A/es unknown
-
2016
- 2016-05-04 HK HK16105095.5A patent/HK1217102A1/zh unknown
-
2018
- 2018-05-31 AU AU2018203833A patent/AU2018203833A1/en not_active Abandoned
- 2018-06-26 US US16/018,357 patent/US20180298003A1/en not_active Abandoned
- 2018-10-09 JP JP2018190645A patent/JP2019014748A/ja active Pending
-
2019
- 2019-01-22 US US16/254,124 patent/US20190389861A1/en not_active Abandoned
-
2020
- 2020-03-23 US US16/827,026 patent/US20200291027A1/en not_active Abandoned
- 2020-11-16 US US17/099,133 patent/US20210070756A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL256946B (en) | Bromodomain inhibitors | |
HK1217102A1 (zh) | 四環布羅莫結構域抑制劑 | |
HK1224297A1 (zh) | 布羅莫結構域抑制劑 | |
HK1218909A1 (zh) | 二氫-吡咯並吡啶酮布羅莫結構域抑制劑 | |
HK1222335A1 (zh) | 新雙環溴結構域抑制劑 |